ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of APOEε4 on Functional Brain Network in Patients with Subjective Cognitive Decline: A Resting State Functional MRI Study

Deng, Simin; Sun, Lingyu; Chen, Weijie; Liu, Xiaorong; Chen, Shangjie*南方医科大学
International Journal of General Medicine2021DOI: 10.2147/IJGM.S342673
1被引6阅读
引用收藏
分享

摘要

Purpose: Subjective cognitive decline (SCD) is the earliest symptom stage of Alzheimer's disease (AD), and the APOE epsilon 4 allele is the strongest genetic risk factor for sporadic AD. Based on graph theory, the resting state functional connectivity (rsFC) in SCD patients with APOE epsilon 4 was studied to explore the effect of APOE epsilon 4 on the rsFC network properties of SCD patients. @@@ Patients and Methods: This cross-sectional study included MRI image data from 19 SCD patients with APOE epsilon 4 (SCD+), 29 SCD patients without APOE epsilon 4 (SCD-), and 30 normal control (NC-) individuals without APOE epsilon 4. We generated a binary matrix based on anatomical automatic labeling (AAL) 90 atlas to construct the functional network. We then calculated the whole brain network characteristics and intracerebral node characteristics by graph theory. @@@ Results: For the whole brain network characteristics, all three groups showed small-worldness. The SCD+ group had increased compensatory information transfer speed and enhanced integration capability. This group also had high heterogeneity for intracerebral node characteristics, mainly in the default mode network, left superior occipital gyms, and bilateral putamen. @@@ Conclusion: APOE epsilon 4 effects the functional brain network in patients with SCD and may be a potential indicator for the identification of SCD.

学科与关键词

关键词
SCDAPOE epsilon 4 allelegraph theorywhole brain network characteristicsintracerebral node characteristics
相关
加载中…
  • Static and dynamic functional connectivity variability of the anterior-posterior hippocampus with subjective cognitive decline
    Wang, Qiang; Chen, Ben; Zhong, Xiaomei; Hou, Le; Zhang, Min; Yang, Mingfeng; Wu, Zhangying; Chen, Xinru; Mai, Naikeng; Zhou, Huarong; Lin, Gaohong; Zhang, Si; Ning, Yuping*Alzheimers Research & Therapy, 2022, 14(1): 122.被引 2
  • APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults
    Scheller, Elisa*; Peter, Jessica; Schumacher, Lena V.; Lahr, Jacob; Mader, Irina; Kaller, Christoph P.; Kloeppel, StefanNeurobiology of Aging, 2017, 56: 127-137.被引 20
  • White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines
    O'Dwyer, Laurence*; Lamberton, Franck; Matura, Silke; Scheibe, Monika; Miller, Julia; Rujescu, Dan; Prvulovic, David; Hampel, HaraldPLoS One, 2012, 7(4): e36024.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of General Medicine
发表日期
2021
卷期
第 14 卷
页码
9761-9771
DOI
10.2147/IJGM.S342673
期刊收录
NSL
期刊等级
3区
成果收录
SSCI · SCIE
资助标注
National Natural Science Foundation of China [81973922]; Dongguan Science and Technology of Social Development Program [202050715046225]; Subject of Shenzhen Science and Technology Innovation Commission [JCYJ20190809151013581]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLC; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; ADNI clinical sites in Canada

作者

  • D

    Deng, Simin (第一作者)

    2 · southern med univ

  • S

    Sun, Lingyu

查看全部 5 位作者收起作者
  • C

    Chen, Weijie

    2 · southern med univ

  • L

    Liu, Xiaorong

  • C

    Chen, Shangjie (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417